To further determine the precise function of IL-2-mediated ERK1/2 activation in ALCL cells, we used the kinase inhibitor U0126, which is specific for MEK1/2, an upstream kinase in the ERK1/2 kinase cascade (51, 54, 55). This evidence concerns the gene MAP2K1 and anaplastic large cell lymphoma.